441 material Form 8-K filings that 376 companies we cover made with the SEC in June 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Guidewire reported unaudited results for the fiscal third quarter ended April 30, 2025, with total revenue of $293.5 million, up 22% from a year earlier, and GAAP net income of $46.0 million, compared with a net loss of $5.5 million a year earlier. The company raised its fiscal 2025 revenue, operating income and operating cash flow targets, citing strong third-quarter execution.
Q3 total revenue was $293.5 million, up 22%; subscription and support revenue rose 32% to $181.8 million.
GAAP net income was $46.0 million, or $0.54 per diluted share, versus a net loss of $0.07 per share a year earlier.
Annual recurring revenue was $960 million as of April 30, 2025, compared with $864 million at July 31, 2024.
Updated fiscal 2025 outlook includes total revenue of $1,178 million to $1,186 million and operating cash flow of $255 million to $275 million.
HealthEquity reported first-quarter results for the period ended April 30, 2025, with revenue of $330.8 million, up 15%, and GAAP net income of $53.9 million, or $0.61 per diluted share, up from $0.33 a year earlier. The company said it increased its full-year fiscal 2026 guidance, now calling for revenue of $1.285 billion to $1.305 billion and GAAP net income per diluted share of $1.96 to $2.13.
Revenue of $330.8 million, up 15% from $287.6 million a year earlier; Adjusted EBITDA of $140.2 million, up 19%
GAAP net income of $53.9 million, or $0.61 per diluted share, versus $28.8 million, or $0.33, in the prior-year quarter
Fiscal 2026 outlook: revenue $1.285 billion to $1.305 billion; Adjusted EBITDA $530 million to $550 million; non-GAAP net income per diluted share $3.61 to $3.78
Company repurchased 0.7 million shares for $60.3 million in the quarter; $117.5 million remained authorized as of April 30, 2025
Ollie's Bargain Outlet reported first quarter fiscal 2025 net sales of $576.8 million, up 13.4%, and diluted EPS of $0.77 versus $0.75 a year earlier. The company reaffirmed its fiscal 2025 adjusted EPS outlook of $3.65 to $3.75 and raised its net sales and comparable store sales ranges. Operating income was slightly lower than a year earlier, and the company cited higher SG&A as a percentage of sales.
Net sales were $576.8 million, up 13.4%, with comparable store sales up 2.6%
Diluted EPS was $0.77 versus $0.75; adjusted diluted EPS was $0.75 versus $0.73
Operating income was $56.2 million versus $56.5 million; SG&A rose to 28.6% of sales from 28.0%
Fiscal 2025 adjusted EPS outlook of $3.65 to $3.75 was reaffirmed; net sales outlook is now $2.579 to $2.599 billion
Signet Jewelers reported first quarter fiscal 2026 results for the 13 weeks ended May 3, 2025, with sales up 2.0% to $1.5 billion and same store sales up 2.5%. The company raised the low end of its fiscal 2026 operating guidance and raised its adjusted diluted EPS guidance to $7.70 to $9.38, citing share repurchases of more than 5% of outstanding shares year to date.
Diluted EPS was $0.78, compared with a loss of $0.90 a year earlier, and includes $0.46 of restructuring charges; adjusted diluted EPS was $1.18 versus $1.11.
GAAP operating income was $48.1 million, down from $49.8 million, while adjusted operating income rose to $70.3 million from $57.8 million.
Fiscal 2026 adjusted diluted EPS guidance was raised to $7.70 to $9.38 from $7.31 to $9.10; total sales guidance is $6.57 to $6.80 billion.
The company repurchased about 2.1 million shares for $117.4 million in the quarter and has nearly $600 million remaining in repurchase authorization.
Dollar General reported first-quarter fiscal 2025 net sales of $10.4 billion, up 5.3%, and diluted earnings per share of $1.78, up 7.9%, for the 13 weeks ended May 2, 2025. The company raised its fiscal 2025 diluted EPS guidance to $5.20 to $5.80 from $5.10 to $5.80, and also raised its net sales and same-store sales growth ranges, while noting uncertainty from tariffs.
Net sales rose 5.3% to $10.4 billion from $9.9 billion; same-store sales rose 2.4%.
Diluted EPS rose to $1.78 from $1.65; net income was $391.9 million.
Fiscal 2025 diluted EPS guidance is $5.20 to $5.80, up from $5.10 to $5.80; the guidance assumes no share repurchases.
Board declared a quarterly dividend of $0.59 per share, payable on or before July 22, 2025, to holders of record on July 8, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.